This week, a Capitol hearing spotlights Medicare fraud gaps, reports warn of equity setbacks, community oncology boosts ...
Community oncology leaders emphasized provider-first AI adoption, starting with clear use cases, defined guardrails, and ...
Rani Bansal, MD, discusses breast cancer subtypes, racial disparities in triple-negative disease, self-advocacy for young ...
Cell and gene therapies have a huge curative potential but come with a large price tag that can result in access barriers. At ...
Emory validated AI outbound calls to collect home BP readings and support technique, improving hypertension star performance ...
The 2025 CAQH Index found that more than $20 billion in cost savings could be achieved with more adoption of automatic and ...
Kaitlyn Schomberg, PharmD, discusses BiTE therapy adoption, toxicity management, and care coordination in community oncology ...
Compared with placebo, semaglutide achieved larger reductions in heavy-drinking days (−41.1 vs −26.4 percentage points) and ...
Chris Johnson, MBA, explains how retail-based pediatric clinics and smart tech can expand Medicaid access and streamline ...
At the IVBM Charlotte event, Seungjean Chai, MD, emphasized that patient-centered design, guidelines, and subspecialty expertise are essential to high-value oncology care.
At the IVBM Charlotte event, Seungjean Chai, MD, emphasized that patient-centered design, guidelines, and subspecialty ...
Marc P. Bonaca, MD, MPH, and Josephine Harrington, MD, discuss the clinical value of the uACR test and why it remains underutilized. Chronic kidney disease (CKD) affects an estimated 37 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results